Robert Redfield - 12 Dec 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Chief Medical Officer
Signature
/s/ Robert Redfield
Issuer symbol
TRAW
Transactions as of
12 Dec 2025
Net transactions value
$0
Form type
4
Filing time
16 Dec 2025, 18:15:29 UTC
Previous filing
15 Oct 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Redfield Robert Chief Medical Officer C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTON /s/ Robert Redfield 16 Dec 2025 0002018274

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRAW Common Stock Award $0 +16,419 +17% $0.000000 113,919 12 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to purchase) Award $0 +65,676 $0.000000 65,676 12 Dec 2025 Common Stock 65,676 $2.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis.
F2 The options vest 100% on the first anniversary of the grant date.